Similar to independent observations in separate cohorts of CLL patients (7–10), serum levels of BAFF were reduced while that of APRIL and sTACI were significantly increased in comparison to WT control mice (Figure 1A). The gene discussed is TNFSF13B; the disease is B-cell chronic lymphocytic leukemia.